Home LiteratureArticle Details
PMID: 6175456 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Clinical and experimental immunology ·Vol. 45 ·No. 3 ·1981-09-00 ·Pages 576-82

Neighbour PA, Grayzel AI

Abstract

The production of interferons (IFN) by peripheral blood leucocytes from normal donors an patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) has been investigated in response to several IFN inducers in vitro. Whereas IFN responses of RA donors did not differ significantly from the normal group, those of SLE patients were significantly reduced, and many of these patients failed to respond to all. Patients with active or acute SLE responded significantly less well than those with inactive disease. There was no apparent effect of steroid therapy on the IFN responses of either SLE or RA patients. These data may indicate a basic immunological defect of the circulating leucocytes of SLE patients, which may be responsible for some of the in vitro lymphocyte anomalies reported for this disease.

MeSH Terms
Adult Arthritis, Rheumatoid/drug therapy,immunology Azathioprine/therapeutic use Cells, Cultured Female Humans Interferon Inducers/pharmacology Interferons/biosynthesis Leukocytes/immunology Lupus Erythematosus, Systemic/drug therapy,immunology Male Middle Aged Prednisone/therapeutic use
Chemicals
Interferon Inducers Interferons Azathioprine Prednisone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Neighbour P A
Grayzel A I
References (20)
20 references, click to expand
  1. Interferon production by human leucocytes in vitro. Reduced levels in lymphatic leukemia.
    Proc Soc Exp Biol Med. 1966 May;122(1):32-9 PMID: 4287659
  2. 1958 Revision of diagnostic criteria for rheumatoid arthritis.
    Bull Rheum Dis. 1958 Dec;9(4):175-6 PMID: 13596783
  3. Leukocyte interferon production, RNA synthesis, and PHA response in patients with infectious mononucleosis.
    Blood. 1973 Aug;42(2):175-85 PMID: 4793109
  4. Interferon production by lymphocytes from patients with systemic lupus erythematosus.
    Arthritis Rheum. 1974 Sep-Oct;17(5):590-2 PMID: 4370121
  5. In vitro leukocyte interferon production in patients with Hodgkin's disease.
    Cancer Res. 1974 Nov;34(11):2995-3002 PMID: 4421578
  6. Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity.
    Arthritis Rheum. 1975 May-Jun;18(3):207-17 PMID: 1095020
  7. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.
    J Clin Invest. 1977 Jan;59(1):106-16 PMID: 830659
  8. Target cells for interferon production in human leukocytes stimulated by sendai virus.
    J Immunol. 1977 Jun;118(6):1931-5 PMID: 193987
  9. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.
    J Exp Med. 1978 May 1;147(5):1299-1313 PMID: 650155
  10. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
    J Exp Med. 1978 May 1;147(5):1314-33 PMID: 650156
  11. Mitogen and antigen induction of interferon in vitro and in vivo.
    Tex Rep Biol Med. 1977;35:42-56 PMID: 358465
  12. Immunoregulatory aberrations in systemic lupus erythematosus.
    J Immunol. 1978 Oct;121(4):1473-9 PMID: 359708
  13. Time and dosage dependence of immunoenhancement by murine type II interferon preparations.
    Cell Immunol. 1978 Oct;40(2):285-93 PMID: 363280
  14. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.
    Immunol Rev. 1979;44:125-163 PMID: 153888
  15. Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.
    Proc Natl Acad Sci U S A. 1979 Jan;76(1):476-80 PMID: 311475
  16. Immune interferon in the circulation of patients with autoimmune disease.
    N Engl J Med. 1979 Jul 5;301(1):5-8 PMID: 449915
  17. Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus.
    Scand J Immunol. 1979;10(3):223-8 PMID: 160613
  18. Natural killer funciton in systemic lupus erythematosus.
    Arthritis Rheum. 1980 Jan;23(1):30-5 PMID: 7352941
  19. Interferon as a mediator of human lymphocyte suppression.
    J Exp Med. 1980 Mar 1;151(3):637-50 PMID: 6444662
  20. Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.
    J Clin Invest. 1969 Apr;48(4):758-67 PMID: 4886647
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1981-09-00
Pages
576-82
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1537416
Subset
IM
Grants
NINDS NIH HHS · NS 11920 · United States
NINDS NIH HHS · NS 15541 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com